Position in MLYS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$537,682
-$43,491,703 QoQ
Shares Held
19,848
-98.4% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $15,213,180,190 across 182 Biotechnology names. MLYS ranks #133 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,541,732 | $1,856,099,791 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
3,458,863 | $1,114,411,067 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,018,647 | $1,056,701,142 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
13,179,013 | $978,673,503 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
16,575,875 | $963,224,094 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,131,527 | $951,812,064 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
9,766,496 | $949,791,733 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
6,945,813 | $641,654,204 |
All Filings in MLYS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $537,682 | 19,848 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $44,029,385 | 1,213,265 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $752,636 | 19,848 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $156,948 | 11,600 | Shares | Defined | 2025-08-14 | |
| 2023-09-30 | $6,330,967 | 665,717 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,955,752 | 407,962 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,284,247 | 337,436 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||